| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/25/1999 | EP0921774A4 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 08/25/1999 | EP0874685B1 Water-redispersible granules including a liquid active material and a non-ionic alkoxyl-type surfactant |
| 08/25/1999 | EP0783482A4 Cationic transport reagents |
| 08/25/1999 | EP0766661B1 Polyolpolyhydroxystearates |
| 08/25/1999 | EP0700290B1 Rectal compositions containing odansetron in its free base form |
| 08/25/1999 | EP0675710B1 Process for preparing controlled release pharmaceutical forms and the forms thus obtained |
| 08/25/1999 | EP0664118B1 Sustained-release tablet |
| 08/25/1999 | EP0661967B1 Combined virustatic antimediator (covam) treatment of common colds |
| 08/25/1999 | EP0572494B1 Composition for use in transdermal administration |
| 08/25/1999 | CN2334406Y Acupuncture point massage medicinal adhesive stick |
| 08/25/1999 | CN1226927A Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 08/25/1999 | CN1226924A Monoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
| 08/25/1999 | CN1226900A Chitin beads, chitosan beads, process for preparing these beads, carrier comprising said beads, and process for preparing microsporidian spore |
| 08/25/1999 | CN1226847A Apparatus for coating foods or pharmaceuticals |
| 08/25/1999 | CN1226842A Preservation by foam formation |
| 08/25/1999 | CN1226835A -i gene transfer methods for wound healing |
| 08/25/1999 | CN1226834A Use of (meth) acrylic acid copolymers to increase permeability of mucous membranes |
| 08/25/1999 | CN1226824A Tramadol multiple unit formulations |
| 08/25/1999 | CN1226822A Capsules for oral preparations and capsule preparations for oral administration |
| 08/25/1999 | CN1226821A Microparticles |
| 08/25/1999 | CN1226816A Oil-in-water emulsion for use on human skin for cleansing, preserving or improving skin condition |
| 08/25/1999 | CN1226584A The production of solid dosage forms |
| 08/25/1999 | CN1226583A The production of solid dosage forms |
| 08/25/1999 | CN1226443A External used ointment for mammary cancer and preparing method thereof |
| 08/25/1999 | CN1226438A Composite mannosans peptides oral liquor |
| 08/25/1999 | CN1226437A Ointment |
| 08/25/1999 | CN1226427A External used Chinese medicine liquid prepared from plants, method and use thereof |
| 08/25/1999 | CN1226425A Lesion-directed antibiotics in dry dosage forms for treatment of shallow ulcers of oral mucosa |
| 08/25/1999 | CN1226424A Slow releasing agent of tuduvanine and its preparing method |
| 08/25/1999 | CN1226422A Percutaneous absorption type preparation |
| 08/25/1999 | CN1226400A Health-care products 'Xinjifen' made from animal hearts |
| 08/25/1999 | CN1044780C External-use acupoint paste for hyposensitizing and cough relieving of asthma, and its preparing process |
| 08/24/1999 | US5942550 Cholesterol lowering drink mix compositions |
| 08/24/1999 | US5942545 Composition and method for treating penile erectile dysfunction |
| 08/24/1999 | US5942512 Method and composition for treating erectile dysfunction |
| 08/24/1999 | US5942510 Lyophilized frozen sterile solution having a bulking agent; an antiepileptic durg |
| 08/24/1999 | US5942508 Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid |
| 08/24/1999 | US5942498 Formulations containing hyaluronic acid |
| 08/24/1999 | US5942496 Methods and compositions for multiple gene transfer into bone cells |
| 08/24/1999 | US5942253 Prolonged release of GM-CSF |
| 08/24/1999 | US5942252 Increasing the bioavailability of a drug by administering an effective amount of microcapsules to animal, the microcapsules comprising active agent encapsulated in a biocompatible and biodegradable excipient |
| 08/24/1999 | US5942251 Pharmaceutical compositions for intranasal administration of dihydroergotamine |
| 08/24/1999 | US5942250 Compositions and methods for enhancing the topical effects of sunscreen agents |
| 08/24/1999 | US5942249 Improved dissolution and absorption of antiplatelet agents, heart stimulants, vasodilator, antagonists, thromboxane synthetase inhibitor |
| 08/24/1999 | US5942248 Pharmaceutical composition containing a low detergent effect bile salt and an active compound that undergoes biliary excretion and/or enterohepatic recycling |
| 08/24/1999 | US5942246 Etherlipid containing multiple lipid liposomes |
| 08/24/1999 | US5942245 Application of SOD in liposomes |
| 08/24/1999 | US5942244 Local oral herbal slow release tablets |
| 08/24/1999 | US5942243 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 08/24/1999 | US5942242 Medicaments for nasal administration |
| 08/24/1999 | US5942241 A sustained release drug containing a substrate comprising a local anesthetic and a biocompatible, biodegradable, controlled release polymer selected from polyanhydrides, lactic acid and glycolic acid homo-or/and copolymers |
| 08/24/1999 | US5942239 A fast-drying skin protectant comprising polyetherurethane copolymer, benzoin gum and solvent providing a dry film that is elastic, vapor permeable, water proof, dirt proof, insect proof, aerobic bacteriostatic, and adheres well to skin |
| 08/24/1999 | US5942237 Pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
| 08/24/1999 | US5942233 Herbal composition for stimulating blood circulation |
| 08/24/1999 | US5942231 Daily bathing in a bathtub with a water-permeable bag containing the dry powder of guava leaves; treatment of allergic diseases |
| 08/24/1999 | US5942216 Water-in-oil-in-water compositions |
| 08/24/1999 | US5942209 Polymerizing a biodegradable, biocompatible polymer vehicle, e.g. epoxide-containing polymer, polyester, polyurethane, polyamide, polysulfone or an addition polymer, containing radionuclides; drug delivery |
| 08/24/1999 | US5941240 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 08/24/1999 | CA2180944C Method for delipidation of skin and cerumen removal |
| 08/24/1999 | CA2110831C Stabilized microspheres and methods of preparation |
| 08/24/1999 | CA2033109C Acrylic gel material and acrylic gel preparation |
| 08/24/1999 | CA2015536C Pharmaceutical formulation |
| 08/24/1999 | CA2010090C Film applicable to oral mucosa and drug preparation comprising the same |
| 08/24/1999 | CA2009065C Use of solutions of atelocollagen and polyholosides, for example glycosaminoglycans, for the manufacture of microcapsules, microcapsules produced in this way, processes for the manufacture of such microcapsules and cosmetic, pharmaceutical or food compositions in which they are present |
| 08/19/1999 | WO1999041298A1 Composite particles containing an active substance |
| 08/19/1999 | WO1999041247A1 TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES |
| 08/19/1999 | WO1999040966A1 Drug delivery system |
| 08/19/1999 | WO1999040955A2 Pressure sensitive adhesive matrix patch for the treatment of onychomycosis |
| 08/19/1999 | WO1999040943A1 Solubilizing delivery systems and method of manufacture |
| 08/19/1999 | WO1999040942A1 Preparations with controlled release |
| 08/19/1999 | WO1999040932A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 08/19/1999 | WO1999040921A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
| 08/19/1999 | WO1999040920A1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
| 08/19/1999 | WO1999040918A1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 08/19/1999 | WO1999040903A1 Transdermal delivery devices |
| 08/19/1999 | WO1999040902A1 Encapsulation system with organic core and mineral cortex based on aluminium hydroxycarbonate and preparation method |
| 08/19/1999 | WO1999040901A1 A consumable gummy delivery system |
| 08/19/1999 | WO1999040900A1 Droperidol compositions and method for using same |
| 08/19/1999 | WO1999040899A1 Implantable device and use thereof |
| 08/19/1999 | WO1999040898A2 Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
| 08/19/1999 | WO1999040889A1 Cosmetic composition containing an aqueous dispersion of insoluble polymer material particles, use and method |
| 08/19/1999 | WO1999040883A2 Compositions and methods for the treatment of cystic fibrosis |
| 08/19/1999 | WO1999040789A1 Methods and compounds for the genetic treatment of hyperlipidemia |
| 08/19/1999 | WO1999030694A3 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 08/19/1999 | WO1999030671A3 Aspected particles for oral delivery |
| 08/19/1999 | WO1999025354A3 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 08/19/1999 | WO1999025322A3 Pharmaceutical compositions having the shape of powders of cross-linked polymers loaded with drugs and related preparation process by supercritical fluids |
| 08/19/1999 | WO1999024024A3 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/19/1999 | WO1999023996A3 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor |
| 08/19/1999 | WO1999021551A9 Matrix for controlled delivery of highly soluble drugs |
| 08/19/1999 | WO1999020256A3 Medicament excipient particles for tissue-specific application of a medicament |
| 08/19/1999 | WO1999016419A9 Perforated microparticles and methods of use |
| 08/19/1999 | WO1999016412A3 Non-irritating cosmetic and pharmaceutical compositions |
| 08/19/1999 | WO1999015210B1 Bioadhesive compositions and methods for topical administration of active agents |
| 08/19/1999 | WO1999012945A3 Hydrophobic glycosylamine derivatives, compositions, and methods for use |
| 08/19/1999 | WO1998008966A8 Loxoprofen-containing preparation for external use |
| 08/19/1999 | WO1997003655A8 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules |
| 08/19/1999 | DE19805572A1 New, stable intercalates of sensitive active agent, e.g. sunscreen, in nanoporous carrier useful as cosmetic and dermatological formulations and also in skin and hair treatment |
| 08/19/1999 | CA2324426A1 Compositions and methods for the treatment of cystic fibrosis |
| 08/19/1999 | CA2320965A1 Methods and compounds for the genetic treatment of hyperlipidemia |